Short answer · Medically reviewed summary · Last updated: 2026-04-07
22q11.2 deletion syndrome, commonly known as 22q11 DiGeorge Syndrome, is a genetic disorder historically identified by several names including Velocardiofacial Syndrome (VFS) and Shprintzen Syndrome. These various labels reflect the condition's wide clinical variability, though medical professionals now prefer the term 22q11.2 deletion syndrome to describe the underlying chromosomal cause accurately. Why does 22q11 DiGeorge Syndrome have so many different names? The history of 22q11 DiGeorge Syndrome is a classic example of how medical nomenclature evolves as scientific understanding improves.
22q11.2 deletion syndrome, commonly known as 22q11 DiGeorge Syndrome, is a genetic disorder historically identified by several names including Velocardiofacial Syndrome (VFS) and Shprintzen Syndrome. These various labels reflect the condition's wide clinical variability, though medical professionals now prefer the term 22q11.2 deletion syndrome to describe the underlying chromosomal cause accurately.
The history of 22q11 DiGeorge Syndrome is a classic example of how medical nomenclature evolves as scientific understanding improves. In the 1960s and 70s, clinicians described patients with distinct clusters of symptoms—such as cardiac defects, thymic hypoplasia, and palate abnormalities—without realizing they all shared the same genetic origin. Consequently, different researchers coined names like DiGeorge Syndrome, Velocardiofacial Syndrome, and Conotruncal Anomaly Face Syndrome. As genetic testing advanced, it was discovered that these were all manifestations of a microdeletion on the long arm of chromosome 22, leading to the consolidation of these names under the umbrella of 22q11.2 deletion syndrome.
When reviewing older medical records or international literature, you may encounter several terms used to describe 22q11 DiGeorge Syndrome. While these terms are increasingly replaced by the chromosomal designation, understanding them is essential for navigating medical history:
In modern clinical practice and international coding systems, the focus has shifted toward the genetic etiology of 22q11 DiGeorge Syndrome. This helps ensure that patients are accurately identified for research and treatment purposes. Major medical classification systems currently use the following designations:
While the name 22q11 DiGeorge Syndrome remains widely recognized by the public and within the DiseaseMaps.org community of 215 members, medical geneticists and pediatric specialists now almost exclusively use 22q11.2 deletion syndrome. This terminology is preferred because it is descriptive, precise, and removes ambiguity regarding the specific genetic mechanism. Using this term during clinical consultations can help ensure that you are receiving the most up-to-date, evidence-based care.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider regarding any medical condition.